A/Prof Rebecca McKetin (BSc(Psychol)Hons. PhD) leads a program of research into stimulant use epidemiology and interventions at the National Drug and Alcohol Research Centre, UNSW. Her current research involves trialling of new pharmacotherapy options for methamphetamine dependence (www.tinatrial.info, www.nicetrial.info; www.limastudy.info) the development of novel responses to methamphetamine use in Aboriginal and Torres Strait Islander communities (www.nimac.org.au), the online delivery of psychological help for people who use stimulants (www.breakingtheice.org.au, www.wecandothis.com.au) and the translation of contingency management for stimulant use into Australian clinical practice. Her work has been pivotal in quantifying the extent of methamphetamine use in Australia and related health outcomes. She is a Senior Editor for Addiction, a consultant to the United Nations, and a member of the Australian Institute of Policy and Science.

Dr Marianne Jauncey has been Medical Director of the Uniting Medically Supervised Injecting Centre (MSIC) since 2008. She is a Public Health Physician who has worked at the pointy end of harm reduction for a decade before MSIC. She began at a primary care centre in Kings Cross called KRC, which provides specialist health care for injecting drug users, sex workers and youth at risk. She has overseen MSIC receiving widespread support and becoming a permanent service, the formation of an MSIC consumer participation group, and a pilot project of client volunteers, Uniting, formally deciding to advocate for drug decriminalisation and launching their campaign at Town Hall with Richard Branson in 2018, and two decades of successful service operation without a single death. She is delighted that she is no longer the only person in Australia with her job title, with Melbourne expecting to open their second MSIC in the coming months.

Carrie Fowlie is the CEO of Hepatitis Australia, the national peak body representing the state and territory hepatitis organisations and the interests of 350,000 Australians impacted by hepatitis B and hepatitis C. Carrie has two decades of peak body, policy and social justice experience. Her collaborative work has resulted in policy, programs and law reform consistent with the evidence and the priorities of her constituencies.